Australia's largest stock trading and investment forum Australia's #1 stock forum

MSB mesoblast limited

0.00%

$2.31

RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-5

First 5 Last

Share
Profile

Follow
vasilios

4,273 Posts.

389

05/01/22

16:12

Post #: 58660758
Share

Originally posted by col69: ↑

Not sure the statistics agree with you on that .... especially given another 1,847 people died on Tuesday 4th Jan from COVID-19 in the USA alone ?

I think Mesoblast have a great case to lobby either the NIH or a new partner to fund this additional phase 3 COVID-19 ARDS trial that they propose to undertake this year ....

..... almost 4 million new COVID-19 cases in the last 7 days is likely to see hospitalisation and death numbers increase over the coming weeks based on previous lags from case number increases and the situations evolving in many states combined with the winter months now upon the USA

I am all for the additional phase 3 COVID-19 ARDS trial as long as Mesoblast don't have to fund it

https://www.worldometers.info/coronavirus/

View attachment 3957110

https://www.worldometers.info/coronavirus/weekly-trends/#weekly_table

View attachment 3957170

Expand

How many of those are unvaxxed? ARDS should be a low priority for MSB.

MSB Price at posting: $1.37 Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

PSC

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

ASX Market Open: After worst day in 3 months, bourse could only really bounce back | July 22

ASX Market Close: Climbing to 8,700s based on vibes wasn't sustainable

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

PTX

This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution

There are more pages in this discussion • 606 more messages in this thread...

First 5 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $2.31		Change 0.000(0.00%)		Mkt cap ! $2.956B

Open	High	Low	Value	Volume
0.0¢	$2.35	$2.15	$341.1K	147.6K

Buyers (Bids)

No.	Vol.	Price($)
1	3065	$2.49

Sellers (Offers)

Price($)	Vol.	No.
$2.17	35	1

View Market Depth

No.	Vol.	Price($)
1	3065	2.490
1	1823	2.450
2	2695	2.410
1	4250	2.400
1	43	2.340

Price($)	Vol.	No.
2.170	35	1
2.200	9022	1
2.240	2560	1
2.290	10000	1
2.300	56367	5

Last trade - 09.41am 22/07/2025 (20 minute delay)

MSB (ASX) Chart

RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-5

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

ASX Market Open: After worst day in 3 months, bourse could only really bounce back | July 22

ASX Market Close: Climbing to 8,700s based on vibes wasn't sustainable

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-5

Top Stories

Prospect's Mumbezhi Project puts it at the middle of copper's megatrend. And FQM just bought in

ASX Market Open: After worst day in 3 months, bourse could only really bounce back | July 22

ASX Market Close: Climbing to 8,700s based on vibes wasn't sustainable

Listen: HotCopper Wire Podcast 018 – Potatoes, TACOs, and the $120M helicopter heist

This rare type of lymphoma ruins the body – so do existing treatments. Prescient could have a solution

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News